Plasma biomarkers predict long‐term longitudinal cognitive decline in individuals at‐risk for Alzheimer's disease: differences across demographic groups

Abstract

Background: Plasma biomarkers are promising tools for detecting Ab pathology in cognitively unimpaired (CU) individuals. However, their association with cognitive trajectories and how this associations vary across demographic subgroups remain unclear.